Yan Xing, Voutetakis Antonis, Zheng Changyu, Hai Bo, Zhang Chunmei, Baum Bruce J, Wang Songlin
Salivary Gland Disease Center and the Molecular Laboratory for Gene Therapy, School of Stomatology, Capital Medical University, Beijing, PR China.
J Gene Med. 2007 Sep;9(9):779-87. doi: 10.1002/jgm.1081.
Gene transfer to salivary glands for use in treating both systemic and upper gastrointestinal tract diseases shows considerable potential. Numerous studies in rodents demonstrate that salivary glands can secrete transgenic secretory proteins either into saliva, primarily via the regulated secretory pathway (RSP), or into the bloodstream, primarily by the constitutive secretory pathway (CSP). The purpose of the present study was to assess the sorting characteristics of human growth hormone (hGH), a RSP protein, and human erythropoietin (hEpo), a CSP protein, in a large animal model of salivary gland gene transfer, the miniature pig.
Recombinant serotype 5 adenoviral (Ad5; 10(11) particles/gland) vectors encoding either hGH (AdCMVhGH) or hEpo (AdCMVhEpo) were administered to both parotid glands of male miniature pigs by intraductal cannulation. The secretion of hGH or hEpo was measured in both saliva and serum on days 3, 7 and 14 following administration. Detailed serum chemistry and hematological analyses were performed, and the presence of serum antibodies to hGH and hEpo was measured. For AdCMVhEpo-treated minipigs vector distribution in multiple tissues was determined by quantitative polymerase chain reaction (QPCR).
The RSP protein hGH was secreted entirely into saliva, while the CSP protein hEpo was secreted into both saliva and serum. Most hEpo was found in saliva, but serum hEpo levels were sufficient to significantly increase hematocrit levels in treated animals by approximately 10%. Expression of both transgenes was maximal on day 3 and declined to near background by day 14. The amount of vector found in the targeted glands was 100 x more than in other tissues.
Secretion of transgenic hGH from minipig parotid glands occurred principally into saliva via the RSP, as seen in rodents, while hEpo was secreted into both saliva and serum, the latter presumably via the CSP. Even though hEpo secretion into the bloodstream was not to the extent previously observed in rodents, serum hEpo levels were considerable and the hEpo was biologically active. Ad5 vector distribution was highly restricted to the parotid glands with little vector detected elsewhere. While the results in this large animal model support the established notion that salivary gland gene transfer can be used for treating systemic single protein deficiency disorders, they also highlight differences in transgenic CSP protein sorting between rodents and miniature pigs.
将基因导入唾液腺用于治疗全身性疾病和上消化道疾病具有巨大潜力。众多在啮齿动物身上进行的研究表明,唾液腺能够将转基因分泌蛋白分泌到唾液中(主要通过调节性分泌途径,即RSP),或者分泌到血液中(主要通过组成型分泌途径,即CSP)。本研究的目的是在唾液腺基因转移的大型动物模型——小型猪中,评估调节性分泌途径蛋白人类生长激素(hGH)和组成型分泌途径蛋白人类促红细胞生成素(hEpo)的分选特性。
通过导管插管将编码hGH(AdCMVhGH)或hEpo(AdCMVhEpo)的重组5型腺病毒(Ad5;10¹¹颗粒/腺体)载体注入雄性小型猪的双侧腮腺。在给药后第3、7和14天测量唾液和血清中hGH或hEpo的分泌情况。进行详细的血清化学和血液学分析,并检测血清中针对hGH和hEpo的抗体。对于接受AdCMVhEpo治疗的小型猪,通过定量聚合酶链反应(QPCR)确定载体在多个组织中的分布。
调节性分泌途径蛋白hGH完全分泌到唾液中,而组成型分泌途径蛋白hEpo则分泌到唾液和血清中。大部分hEpo存在于唾液中,但血清hEpo水平足以使治疗动物的血细胞比容水平显著提高约10%。两种转基因的表达在第3天达到最大值,到第14天降至接近背景水平。在目标腺体中发现的载体量比其他组织多100倍。
小型猪腮腺分泌的转基因hGH主要通过调节性分泌途径分泌到唾液中,这与在啮齿动物中观察到的情况相同,而hEpo则分泌到唾液和血清中,后者可能是通过组成型分泌途径。尽管hEpo分泌到血液中的程度不如之前在啮齿动物中观察到的那样,但血清hEpo水平相当可观,且hEpo具有生物活性。Ad5载体的分布高度局限于腮腺,在其他地方几乎检测不到载体。虽然这个大型动物模型的结果支持了唾液腺基因转移可用于治疗全身性单蛋白缺乏症这一既定观点,但它们也突出了啮齿动物和小型猪之间转基因组成型分泌途径蛋白分选的差异。